ClinicalTrials.gg
RecruitingNCT04160533Updated Apr 13, 2026

Registry of Arterial Hypertension

An observational study in Arterial Hypertension, sponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation. Recruiting at 17 sites in Russia. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-04-13.

Sponsored by National Medical Research Center for Cardiology, Ministry of Health of Russian Federation · Observational

How we know

From the registry’s dates

  • Started Jun 2018; still recruiting 8 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
10,400
Ages
18 Years to 99 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Hypertension with a site in Russia — 2 open to participants now, 4 under way, none of them phase 3. Hypertension · Russia.

Started
2018
the only one that year
Observational
5 of 10
1 open now
Registered
1st of 10
by date
Lead sponsor
1 of 10
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Among the 10 studies in Hypertension with a site in Russia, this one is the only one that started in 2018, is one of 5 observational ones, and was the 1st registered.

Hypertension

6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.

Browse Hypertension studies →

Open to participants now

2 of the 10 studies in Hypertension with a site in Russia are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Russia have not opened yet or have stopped. Only those recruiting at a site in Russia →

Who these studies take

Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.

This study: 18 Years to 99 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Hypertension with a site in Russia, or all of them as a file.
02

Study summary

The problem of the quality of primary health care medical system for patients with arterial hypertension is acute for the investigator's country, as these diseases are the most common and cause the high mortality of the population.

The concept of "quality of primary health care medical system" includes its timeliness, accessibility and provision of medical care to the patient at the modern level, which is determined by the degree of performance by doctors of medical and diagnostic measures corresponding current clinical recommendations.

The system of cardiovascular desease registries, established in the Federal State Clinical Hospital of the Russian Federation Ministry of Public Health with the automated analysis of data on examination and treatment, in comparison with clinical Recommendations. It makes possibility to identify shortcomings and develop approaches to improving the provision of medical care to patients in real clinical practice.

Comparative analysis of the quality of examination and treatment in different samples of patients with cardiovascular desease, observed in 2018-2020, compared with results of previous years will identify ptrends in the provision of medical care to patients with cardiovascular desease.

Read the detailed description

The study will be conducted using the arterial hypertension registry method, which is a computer program with remote access that allows online collection medical data from medical primary care system. To minimize operator errors, doctors was trained before the work with the arterial hypertension registry. User's guide was developed and the rights of users was determined. Data of examination and treatment of patients from 18 years and older with an established diagnosis of hypertension will be added from outpatient cards into the registry of the arterial hypertension. The information is received by the Institution in an impersonal form through a certified dedicated security channel. Patients sign an informed consent for entering their medical data into the registry of arterial hypertension

03

Conditions studied

  • Arterial Hypertension

Browse trials for

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

outpatient patients from 18 to 99 years old with a diagnosis of hypertension

Eligibility criteria

Inclusion Criteria: The diagnosis of arterial hypertension -

Exclusion Criteria: No diagnosis of arterial hypertension

-

05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
10,400 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Number of patients with blood pressure <140/90 mm Hg

    The level of systolic and diastolic blood pressure measured according to the rules described in the clinical guidelines for the treatment and diagnosis of arterial hypertension of the European Society of Cardiology during the visit (mmHg) is entered into the database by doctors.

    Time frame: 2018 - 2021 years

Secondary outcomes

  1. Number of patients with a history of myocardial infarction, chronic renal desease, chronic heart failure, atrial fibrillation.

    Diagnosis data is entered by doctors as a "yes" or "no" category.

    Time frame: 2018-2021

  2. Antihypertensive medications

    Antihypertensive drugs the patient takes are entered into the database. Drugs are analyzed by groups and daily dosages

    Time frame: 2018-2021

07

Study locations

17 of 17 sites recruiting
  • Federal State Budgetary Institution "National Medical Research Center of Cardiology named after academician E.I. Chazov" of the Ministry of Healthcare of the Russian Federation
    Moscow, Moscow Oblast 121552, Russia
    Recruiting
  • State Healthcare Institution "Engels City Polyclinic No. 2
    Engel's, Russia
    Recruiting
  • State Healthcare Institution "Engels City Polyclinic No. 4
    Engel's, Russia
    Recruiting
  • State budgetary health institution of the Kemerovo region "Kemerovo Regional Clinical Cardiology Dispensary named after Academician L.S. Barbarash
    Kemerovo, Russia
    Recruiting
  • State budgetary institution of the ryazan region "regional clinical cardiological dispensary"
    Ryazan, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №1
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №2
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №3
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №1" Taganrog Branch №4
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №1
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health "City polyclinic №2" Taganrog Branch №4
    Taganrog, Russia
    Recruiting
  • Municipal budgetary institution of public health services "City ambulance hospital" city of Taganrog
    Taganrog, Russia
    Recruiting
  • State Autonomous Healthcare Institution of the Tyumen Region "Tyumen Institute of Therapy
    Tyumen, Russia
    Recruiting
  • Municipal Health Institution "City Hospital No. 1" Volgodonsk
    Volgodonsk, Russia
    Recruiting
  • Municipal health institution "City polyclinic №1" Volgodonsk
    Volgodonsk, Russia
    Recruiting
  • Municipal health institution "City polyclinic №3" Volgodonsk
    Volgodonsk, Russia
    Recruiting
  • State budgetary institution of public health "Volgograd regional clinical hospital No. 1" clinic
    Volgograd, Russia
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2018 (actual). Primary completion is estimated for Dec 2026, 102 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 29, 2019
First posted
Nov 13, 2019
StartActual
Jun 1, 2018
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 2026
Last update
Apr 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04160533
Lead sponsor
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
Responsible party
Sponsor
First posted
Nov 13, 2019
Start date
Jun 1, 2018
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Apr 13, 2026

Study contacts

Anna Aksenova, MD
Contact
aksenovaannav@gmail.com
+74954146186

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion